LAVA Medtech Acquisition Corp. Warrants
LVACW
LVACW was delisted on the 12th of May, 2023.
32 hedge funds and large institutions have $2.92M invested in LAVA Medtech Acquisition Corp. Warrants in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
39% more capital invested
Capital invested by funds: $2.09M → $2.92M (+$825K)
10% more funds holding
Funds holding: 29 → 32 (+3)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
+$50K |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$40.8K |
| 3 |
AGM
Alpine Global Management
New York
|
+$11.1K |
| 4 |
EFI
EHP Funds Inc
Toronto,
Canada
|
+$8.42K |
| 5 |
CM
Cohanzick Management
Pleasantville,
New York
|
+$5.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GL
Governors Lane
New York
|
-$86K |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
-$23K |
| 3 |
GCL
Glazer Capital LLC
New York
|
-$2.9K |
| 4 |
SCM
Saba Capital Management
New York
|
-$276 |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
-$49 |
LVACW Hedge Fund Activity: Q2 2022 in Review
32 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q2 2022, worth a combined $2.92M — up 39% from $2.09M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new LVACW positions and 2 closed out — a net gain of 3 holders — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Fort Baker Capital Management, opening a new position worth an estimated $50K. The largest seller was Governors Lane, exiting entirely with an estimated $86K sold.
- 32 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q2 2022, up from 29 in Q1 2022.
- Funds reported $2.92M of LAVA Medtech Acquisition Corp. Warrants stock for Q2 2022, up 39% quarter-over-quarter.
- 5 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q2 2022 and 2 closed out, a net change of +3 holders.
- The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q2 2022 was Fort Baker Capital Management, an estimated $50K added.
- The largest LAVA Medtech Acquisition Corp. Warrants seller in Q2 2022 was Governors Lane, an estimated $86K sold.
Based on aggregated 13F filings for Q2 2022.